Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Weis Bjerrum

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Leukemia Research|August 11, 2012
Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillanceVibe Skov, Thomas Stauffer Larsen, Mads Thomassen, et al.
Acta Oncologica (Stockholm, Sweden)|June 11, 2014
Eosinophilia in routine blood samples as a biomarker for solid tumor development - A study based on the Copenhagen Primary Care Differential Count (CopDiff) DatabaseChristen Lykkegaard Andersen, Volkert Dirk Siersma, Hans Carl Hasselbalch, et al.
Danish Medical Journal|March 3, 2012
Systemic mastocytosis--a systematic reviewChristen Lykkegaard Andersen, Thomas Kielsgaard Kristensen, Marianne Tang Severinsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory proteinMarcus Järås, Petra Johnels, Nils Hansen, et al.
Transfusion|November 6, 2018
Apheresis principles in a patient with chronic myeloid leukemia during pregnancy: challenges in cell separation and assessing transcript levelsKit Peiter Lund, Maria Torp Larsen, Eva Kannik Haastrup, et al.
Hematology (Amsterdam, Netherlands)|November 28, 2009
Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remissionThomas Stauffer Larsen, Michael Boe Møller, Karin de Stricker, et al.
Plos One|November 15, 2014
Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progressionHans Carl Hasselbalch, Mads Thomassen, Caroline Hasselbalch Riley, et al.
Experimental Hematology|January 13, 2009
Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineageMarcus Järås, Petra Johnels, Helena Agerstam, et al.
Ugeskrift for Laeger|September 28, 2018
[Eosinophilia]Ole Weis Bjerrum, Daniel El Fassi, Gitte Madsen, et al.
Clinical Epidemiology|November 9, 2016
The Danish National Chronic Myeloid Neoplasia RegistryMarie Bak, Else Helene Ibfelt, Thomas Stauffer Larsen, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Leukemia Research|August 11, 2012
Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillanceVibe Skov, Thomas Stauffer Larsen, Mads Thomassen, et al.
Acta Oncologica (Stockholm, Sweden)|June 11, 2014
Eosinophilia in routine blood samples as a biomarker for solid tumor development - A study based on the Copenhagen Primary Care Differential Count (CopDiff) DatabaseChristen Lykkegaard Andersen, Volkert Dirk Siersma, Hans Carl Hasselbalch, et al.
Danish Medical Journal|March 3, 2012
Systemic mastocytosis--a systematic reviewChristen Lykkegaard Andersen, Thomas Kielsgaard Kristensen, Marianne Tang Severinsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory proteinMarcus Järås, Petra Johnels, Nils Hansen, et al.
Transfusion|November 6, 2018
Apheresis principles in a patient with chronic myeloid leukemia during pregnancy: challenges in cell separation and assessing transcript levelsKit Peiter Lund, Maria Torp Larsen, Eva Kannik Haastrup, et al.
Hematology (Amsterdam, Netherlands)|November 28, 2009
Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remissionThomas Stauffer Larsen, Michael Boe Møller, Karin de Stricker, et al.
Plos One|November 15, 2014
Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progressionHans Carl Hasselbalch, Mads Thomassen, Caroline Hasselbalch Riley, et al.
Experimental Hematology|January 13, 2009
Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineageMarcus Järås, Petra Johnels, Helena Agerstam, et al.
Ugeskrift for Laeger|September 28, 2018
[Eosinophilia]Ole Weis Bjerrum, Daniel El Fassi, Gitte Madsen, et al.
Clinical Epidemiology|November 9, 2016
The Danish National Chronic Myeloid Neoplasia RegistryMarie Bak, Else Helene Ibfelt, Thomas Stauffer Larsen, et al.
Pageof 7